8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 13, 2026

Sono-Tek Corporation

(Exact name of registrant as specified in its charter)

Commission File Number:

001-40763

New York	14-1568099
(State of Incorporation)	(I.R.S. Employer ID No.)
2012 Route 9W, Milton, New York	12547
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (845) 795-2020

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading<br><br>Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value per share	SOTK	NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02: Results of Operations and Financial Condition.

Item 7.01: Regulation FD Disclosure

On January 13, 2026, Sono-Tek Corporation issued a press release regarding its financial results for the quarter ended November 30, 2025 in the form attached as exhibit 99.1.

The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01: Financial Statements and Exhibits.

(d) Exhibits

99.1       Press Release dated January 13, 2026.

104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SONO-TEK CORPORATION

By: /s/ Stephen J. Bagley

Stephen J. Bagley

Chief Financial Officer

January 13, 2026

Exhibit 99.1

Sono-Tek Reports Fiscal Third Quarter and Nine-Month Fiscal2026 Financial Results

Seventh Consecutive Quarter of Revenue Over $5Million Driven by Continued Strength in Medical Market and High-ASP Production Systems

Gross Margin Expands to 50% in the Quarter and51% Year-to-Date

Third Quarter and Nine-Month Net Income Increased24% and 32% Respectively

Backlog Reaches Record $12.3 Million ReflectingContinued Order Momentum

Reiterates Full Year FY 2026 Guidance AnticipatingModest Revenue Growth

---

MILTON, N.Y., January 13, 2026 – Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the third quarter and first nine months of fiscal year 2026, ended November 30, 2025.

Third Quarter Fiscal 2026 Highlights

·	Net sales for the quarter were $5.0 million, compared with $5.2 million in the prior-year period. This<br>marked the seventh consecutive quarter with revenue exceeding $5 million.
·	Gross profit increased 7% year over year to $2.5 million, with gross margin expanding to 50%, up from<br>45% in the prior-year quarter.
---	---
·	Operating income increased 61% to $319 thousand, reflecting improved gross margin and operating leverage.
---	---
·	Net income increased 24% to $340 thousand, or $0.02 per diluted share, compared with $274 thousand, or<br>$0.02 per diluted share, in the prior-year quarter.
---	---

First Nine Months Fiscal 2026 Highlights

·	Net sales for the first nine months totaled $15.3 million, essentially flat year over year.
·	Gross profit increased 6% to $7.8 million, with gross margin expanding to 51% from 48% in the prior-year<br>period.
---	---
·	Operating income increased 69% to $1.22 million.
---	---
·	Net income increased 32% to $1.25 million, or $0.08 per diluted share, compared with $0.06 per diluted<br>share in the prior-year period.
---	---

Balance Sheet, Backlog and Guidance for Fiscal Year 2026

·	The Company ended the quarter with $11.7 million in cash, cash equivalents and marketable securities and<br>no outstanding debt.
·	Total backlog reached a record $12.26 million, increasing 16% year over year and 9% sequentially, reflecting<br>continued strength in customer order activity.
---	---
·	For the full fiscal year, the Company is reiterating its guidance reflecting an improved but watchful<br>outlook, anticipating modest revenue growth, that balances market adjustments to recent governmental deemphasis of clean energy initiatives<br>and evolving tariff policies with a positive offset from growing demand in the medical device market.
---	---

Management Commentary

Dr. Christopher L. Coccio, Executive Chairman, stated, “We delivered another solid quarter marked by our seventh consecutive period of revenue above $5 million, continued profitability, and meaningful margin expansion. The improvement in gross margin reflects the success of our strategy to prioritize higher-ASP production systems and maintain disciplined cost management, even as certain end markets experience near-term variability. Reaching a record backlog is particularly encouraging and highlights sustained customer confidence in Sono-Tek’s technology and long-term value proposition.”

Steve Harshbarger, CEO & President, added**,** “Demand for our advanced ultrasonic coating platforms remains strong, led by continued momentum in the medical device market and increasing adoption of high-value production systems. While U.S. alternative energy demand softened as anticipated due to policy-related timing shifts, growth across medical, electronics, and industrial applications more than offset this impact. With a strong balance sheet, record backlog, and an expanding mix of high-ASP systems, we are well positioned to drive consistent performance and long-term growth.

Third Quarter Fiscal 2026 Results
(Narrative compares with prior-year period unless otherwise noted) ($ in thousands)
	Three Months Ended November 30,				Change
---	---	---	---	---	---	---
	2025		2024		$	%
Net Sales	$	5,004	$	5,191	(187)	(4%)
Gross Profit	$	2,512	$	2,343	169	7%
Gross Profit %		50%		45%
Operating Income	$	319	$	198	121	61%
Operating Margin		6%		4%
Net Income	$	340	$	274	66	24%
Net Margin		7%		5%

Third Quarter Fiscal 2026 Product and Market Highlights

·	Product Categories
o	In-Line Coating Systems (previously referred<br>to as Integrated Coating Systems) revenue increased sharply by 2,177%, driven by shipments of high-ASP production systems to a<br>major solar energy customer.
---	---
o	Multi-Axis Coating Systems declined 53% year over year due to reduced electrolysis-related demand following<br>shifts in U.S. policy incentives.
---	---
o	OEM Systems revenue increased 64%, reflecting stronger demand from fluxing and medical OEM partners.
---	---
o	Fluxing Systems revenue increased 213%, driven primarily by stronger demand in Asia.
---	---
·	End Markets
---	---
o	Medical sales increased 27%, supported by strong demand for balloon catheter, stent, and diagnostic device<br>coating systems.
---	---
o	Electronics/Microelectronics sales increased 27%, reflecting increased fluxing demand and a semiconductor<br>system shipment to South Korea.
---	---
o	Industrial sales increased 116%, due to the shipment of a large, advanced textile coating platform to<br>a U.S. government-related customer.
---	---
o	Alternative Energy sales declined 35% due to reduced U.S. electrolysis activity following changes in government<br>policy initiatives.
---	---

Geographic Highlights

·	U.S. & Canada sales increased 21% in the quarter, supported by shipments of high-ASP integrated coating<br>systems.
·	Asia Pacific sales declined 34% in the quarter following a strong prior year<br>quarter.
---	---
·	Latin America sales declined 50% due to slower fluxing activity in Mexico and the non-recurrence of a<br>prior-year orthopedic system shipment.
---	---
·	EMEA sales decreased 26% due primarily to softer demand in the advanced energy market, particularly within<br>electrolysis and fuel cell applications.
---	---
Nine Month Fiscal 2026 Results
---
(Narrative compares with prior-year period unless otherwise noted)  ($ in thousands)

---

	Nine Months Ended November 30,				Change
	2025		2024		$	%
Net Sales	$	15,300	$	15,383	(83)	(1%)
Gross Profit	$	7,766	$	7,314	452	6%
Gross Profit %		51%		48%
Operating Income	$	1,223	$	722	501	69%
Operating Margin		8%		5%
Net Income	$	1,249	$	946	303	32%
Net Margin		8%		6%

First Nine-Month Fiscal 2026 Product and Market Highlights

·	Product Categories
o	In-Line Coating Systems (previously referred to as Integrated Coating Systems) revenue increased by 126%,<br>reflecting shipments of 8 high-ASP production systems totaling approximately $5.9M to a major solar energy<br>customer.
---	---
o	Multi-Axis Coating Systems declined 46% year over year primarily due to slower<br>electrolysis system demand following government policy changes.
---	---
o	OEM Systems revenue increased 18%, reflecting stronger demand from fluxing OEM partners.
---	---
o	Fluxing Systems revenue increased 80%, driven primarily by stronger demand in Asia.
---	---
·	End Markets
---	---
o	Medical sales increased 37%, supported by strong balloon coating systems<br>shipped to the U.S., Europe, and China, solid stent coating activity, and expanding new applications in the medical field.
---	---
o	Electronics/Microelectronics sales decreased 9%, following strong FY2025<br>semiconductor sales, and FY2026 customer timing for similar machines.
---	---
o	Industrial sales decreased 26%, influenced by a large FY2025 European glass<br>coating order that did not repeat.
---	---
o	Alternative Energy sales declined slightly by 2% influenced by the shipment<br>of eight high-ASP solar coating systems to the solar industry, which offset declines from the US electrolysis market.
---	---

Geographic Highlights

·	U.S. & Canada sales increased 3%, supported by shipments of high-ASP in-line coating systems.
·	Asia Pacific sales increased 13% driven by medical sales in China and strong alternative energy demand<br>in Japan and South Korea.
---	---
·	Latin America sales declined 48% due to slower fluxing activity in Mexico.
---	---
·	EMEA sales decreased 9% primarily due to softening advanced energy demand in electrolysis and fuel cell<br>applications, partially offset by continued strength in medical system shipments.
---	---

About Sono-Tek

Sono-Tek Corporation (Nasdaq: SOTK) is a global leader in the design and manufacture of ultrasonic coating systems that are shaping industries and driving innovation worldwide. Our ultrasonic coating systems are used to apply thin films onto parts in diverse industries including medical devices, semiconductors, microelectronics, alternative energy, advanced industrial manufacturing, and research and development sectors.

Sono-Tek has a long history of providing advanced coating solutions to the medical device industry, enabling precision coatings for life-saving technologies such as stents, balloons, diagnostic devices, and various drug delivery platforms. At the same time, our expertise in semiconductor and microelectronics applications continues to expand, as customers increasingly turn to Sono-Tek for solutions supporting next-generation chips, displays, and sensors. Alongside these markets, our technologies are also leading the way in next-generation clean energy coatings for fuel cells, carbon capture, advanced solar cells, and various other advanced industrial applications, underscoring the versatility and broad reach of Sono-Tek’s ultrasonic coating platforms.

Our product line is rapidly evolving, transitioning from R&D tools to high-volume production machines with significantly higher average selling prices, showcasing our market leadership and adaptability. Our comprehensive suite of thin film coating solutions and application consulting services ensures unparalleled results for our clients and helps some of the world’s most promising companies achieve technological breakthroughs and bring them to market. We strategically deliver our products to customers through a network of direct sales personnel, carefully chosen independent distributors, and experienced sales representatives, ensuring efficient market reach across diverse sectors around the globe.

Our growth strategy is focused on leveraging our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop microscopic coating technologies that enable better outcomes for our customers’ products and processes. For further information, visit www.sono-tek.com.

---

Safe Harbor Statement

This news release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These “forward-looking statements’ are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions, including political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; inflationary and supply chain pressures; continued strength of sales to the medical device market; continued private and public funding for the clean energy sector; continued strong demand for Sono-Tek’s suite of thin film coating solutions and application consulting services in the clean energy and other markets; maintenance of order backlog; evolving tariff policies; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; consummation of order proposals; completion of large orders on schedule and on budget; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of quarterly and annual revenues within the forecasted range of sales guidance. We undertake no obligation to update any forward-looking statement.

For more information:

Sono-Tek Corp.

Stephen J. Bagley

Chief Financial Officer

Ph: (845) 795-2020

info@sono-tek.com

Investor Relations

Kirin Smith

PCG Advisory, Inc.

ksmith@pcgadvisory.com

-FINANCIAL TABLES FOLLOW -

---

---

---

---

SONO-TEK CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

			February 28,<br> 2025
ASSETS
Current Assets:
Cash and cash equivalents	5,395,695		$	5,202,361
Marketable securities	6,323,566			6,727,678
Accounts receivable (less allowance of 12,225, respectively)	4,411,663			2,347,764
Inventories	3,656,898			4,474,401
Prepaid expenses and other current assets	305,690			236,261
Total current assets	20,093,512			18,988,465
Land	250,000			250,000
Buildings, equipment, furnishings and leasehold improvements, net	2,288,462			2,610,600
Intangible assets, net	31,794			37,386
Deferred tax asset	1,266,846			1,525,185
TOTAL ASSETS	23,930,614		$	23,411,636
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	534,692		$	859,483
Accrued expenses	2,008,801			1,718,574
Customer deposits	2,151,930			2,413,195
Income taxes payable	43,422			496,055
Total current liabilities	4,738,845			5,487,307
Deferred tax liability	59,349			132,134
Total liabilities	4,798,194			5,619,441
Commitments and Contingencies (Note 10)
Stockholders’ Equity
Common stock, .01 par value; 25,000,000 shares authorized, 15,754,480 issued and 15,710,389 outstanding as of November 30, 2025 and 15,751,153 issued and 15,749,037 outstanding February 28, 2025, respectively	157,545			157,512
Additional paid-in capital	10,260,711			10,018,034
Accumulated earnings	8,873,153			7,624,516
Treasury stock, at cost 44,091 shares and 2,116 shares, November 30, 2025 and February 28, 2025, respectively	(158,989	)		(7,867	)
Total stockholders’ equity	19,132,420			17,792,195
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	23,930,614		$	23,411,636

All values are in US Dollars.

See notes to unaudited condensed consolidated financial statements.

SONO-TEK CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

	Nine Months Ended<br> November 30,				Three Months Ended<br> November 30,
	2025		2024		2025			2024
Net Sales	$	15,299,839	$	15,383,416	$	5,004,370		$	5,190,596
Cost of Goods Sold		7,533,347		8,069,633		2,492,129			2,847,397
Gross Profit		7,766,492		7,313,783		2,512,241			2,343,199
Operating Expenses
Research and product development costs		1,934,109		2,054,846		638,361			627,543
Marketing and selling expenses		2,656,804		2,814,804		927,300			929,196
General and administrative costs		1,952,085		1,722,210		627,608			588,823
Total Operating Expenses		6,542,998		6,591,860		2,193,269			2,145,562
Operating Income		1,223,494		721,923		318,972			197,637
Interest and Dividend Income		332,147		359,248		108,487			131,518
Net unrealized gain/(loss) on marketable securities		912		38,776		(658	)		(15,165	)
Income Before Income Taxes		1,556,553		1,119,947		426,801			313,990
Income Tax Expense		307,916		174,247		86,842			39,812
Net Income	$	1,248,637	$	945,700	$	339,959		$	274,178
Basic Earnings Per Share	$	0.08	$	0.06	$	0.02		$	0.02
Diluted Earnings Per Share	$	0.08	$	0.06	$	0.02		$	0.02
Weighted Average Outstanding Shares - Basic		15,721,548		15,750,980		15,708,817			15,751,153
Weighted Average Outstanding Shares - Diluted		15,736,330		15,771,039		15,724,960			15,771,511

See notes to unaudited condensed consolidated financial statements.

---

SONO-TEK CORPORATION

PRODUCT, MARKET, AND GEOGRAPHIC SALES

(Unaudited)

Product Sales

	Three Months Ended <br> November 30,				Change					Nine Months Ended <br> November 30,				Change
	2025		2024				%			2025		2024				%
Fluxing Systems	$	222,000	$	71,000				213%		$	583,000	$	324,000				80%
In-Line Coating Systems		1,844,000		81,000				2,177%			6,428,000		2,850,000				126%
Multi-Axis Coating Systems		1,666,000		3,563,000		)		(53%	)		4,373,000		8,158,000		)		(46%	)
OEM Systems		425,000		259,000				64%			936,000		796,000				18%
Other		847,000		1,217,000		)		(30%	)		2,980,000		3,255,000		)		(8%	)
TOTAL	$	5,004,000	$	5,191,000		)		(4%	)	$	15,300,000	$	15,383,000		)		(1%	)

All values are in US Dollars.

---

Market Sales

	Three Months Ended <br> November 30,				Change					Nine Months Ended <br> November 30,				Change
	2025		2024				%			2025		2024				%
Electronics/Microelectronics	$	1,287,000	$	1,016,000				27%		$	3,686,000	$	4,060,000		)		(9%	)
Medical		1,136,000		897,000				27%			2,949,000		2,156,000				37%
Alternative Energy		1,912,000		2,959,000		)		(35%	)		7,592,000		7,740,000		)		(2%	)
Emerging R&D and Other		18,000		17,000				6%			65,000		57,000				14%
Industrial		651,000		302,000				116%			1,008,000		1,370,000		)		(26%	)
TOTAL	$	5,004,000	$	5,191,000		)		(4%	)	$	15,300,000	$	15,383,000		)		(1%	)

All values are in US Dollars.

Geographic Sales

	Three Months Ended <br> November 30,				Change					Nine Months Ended <br> November 30,				Change
	2025		2024				%			2025		2024				%
U.S. & Canada	$	3,415,000	$	2,823,000				21%		$	9,674,000	$	9,409,000				3%
Asia Pacific (APAC)		734,000		1,114,000		)		(34%	)		2,262,000		1,994,000				13%
Europe, Middle East, Asia (EMEA)		706,000		957,000		)		(26%	)		3,027,000		3,338,000		)		(9%	)
Latin America		149,000		297,000		)		(50%	)		337,000		642,000		)		(48%	)
TOTAL	$	5,004,000	$	5,191,000		)		(4%	)	$	15,300,000	$	15,383,000		)		(1%	)

All values are in US Dollars.